Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sjemmeri who wrote (17190)	6/12/2003 4:21:38 AM
From: Bob Rudd	Read Replies (1) of 78745

Avoids: Biotech direct investments - Use HQH CEF - diversification & expertise at a discount. Litigation risk: Companies with potential killer exposures like asbestos, tobacco that are unpredictable and unquantifiable Regulatory risk: Gov't controls profitability - I now know that the gov't is ready willing and able to bankrupt an industry with price controls - they did it with nursing homes. I'm leary they may do it to Drug industry. Heavy insider selling: Almost always indicates big problems if insider selling jumps way above 'normal' levels. There's got to be a helluva I like about a co and it's valuation to offset this - MAXS would be one where I ignore this 'avoid' None of the above 'avoids' is absolute...individual factors may offset these 'avoid' risks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next